Cargando…
DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
Close to half of de novo acute myeloid leukemia (AML) cases do not exhibit any cytogenetic aberrations. In this regard, distortion of the DNA methylation setting and the presence of mutations in epigenetic modifier genes can also be molecular drivers of the disease. In recent years, somatic missense...
Autores principales: | Ferreira, H J, Heyn, H, Vizoso, M, Moutinho, C, Vidal, E, Gomez, A, Martínez-Cardús, A, Simó-Riudalbas, L, Moran, S, Jost, E, Esteller, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705435/ https://www.ncbi.nlm.nih.gov/pubmed/26434589 http://dx.doi.org/10.1038/onc.2015.359 |
Ejemplares similares
-
Erratum: DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
por: Ferreira, H J, et al.
Publicado: (2017) -
Whole-genome bisulfite DNA sequencing of a DNMT3B mutant patient
por: Heyn, Holger, et al.
Publicado: (2012) -
Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs
por: Nogales, Vanesa, et al.
Publicado: (2015) -
Epigenetic loss of the RNA decapping enzyme NUDT16 mediates C-MYC activation in T-cell acute lymphoblastic leukemia
por: Anadón, C, et al.
Publicado: (2017) -
Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish
por: Lu, J-W, et al.
Publicado: (2017)